| Multicenter evaluation of the prostate health index to detect aggressive prostate cancer in biopsy naive men C de la Calle, D Patil, JT Wei, DS Scherr, L Sokoll, DW Chan, J Siddiqui, ... The Journal of urology 194 (1), 65-72, 2015 | 212 | 2015 |
| Association between combined TMPRSS2: ERG and PCA3 RNA urinary testing and detection of aggressive prostate cancer MG Sanda, Z Feng, DH Howard, SA Tomlins, LJ Sokoll, DW Chan, ... JAMA oncology 3 (8), 1085-1093, 2017 | 146 | 2017 |
| Semantics in active surveillance for men with localized prostate cancer—results of a modified Delphi consensus procedure SM Bruinsma, MJ Roobol, PR Carroll, L Klotz, T Pickles, CM Moore, ... Nature Reviews Urology 14 (5), 312, 2017 | 107 | 2017 |
| Reasons for Discontinuing Active Surveillance: Assessment of 21 Centres in 12 Countries in the Movember GAP3 Consortium M Van Hemelrijck, X Ji, J Helleman, MJ Roobol, W van der Linden, ... European urology 75 (3), 523-531, 2019 | 73 | 2019 |
| The Movember Foundation's GAP3 cohort: a profile of the largest global prostate cancer active surveillance database to date SM Bruinsma, L Zhang, MJ Roobol, CH Bangma, EW Steyerberg, ... BJU international 121 (5), 737-744, 2018 | 64 | 2018 |
| Patient frailty and discharge disposition following radical cystectomy JA Pearl, D Patil, CP Filson, S Arya, M Alemozaffar, VA Master, K Ogan Clinical genitourinary cancer 15 (4), e615-e621, 2017 | 61 | 2017 |
| Cytoreductive nephrectomy for renal cell carcinoma with venous tumor thrombus JE Abel, PE Spiess, V Margulis, VA Master, M Mann, K Zargar-Shoshtari, ... Journal of Urology 198 (2), 281-288, 2017 | 59 | 2017 |
| Circulating microRNAs in plasma as potential biomarkers for the early detection of prostate cancer AC McDonald, M Vira, J Shen, M Sanda, JD Raman, J Liao, D Patil, ... The Prostate 78 (6), 411-418, 2018 | 51 | 2018 |
| Adoption of Prebiopsy Magnetic Resonance Imaging for Men Undergoing Prostate Biopsy in the United States W Liu, D Patil, DH Howard, RH Moore, H Wang, MG Sanda, CP Filson Urology 117, 57-63, 2018 | 49 | 2018 |
| epiCaPture: a urine DNA methylation test for early detection of aggressive prostate cancer E O’Reilly, AV Tuzova, AL Walsh, NM Russell, O O’Brien, S Kelly, ... JCO precision oncology 3, 1-18, 2019 | 45 | 2019 |
| Onodera's Prognostic Nutritional Index as an independent prognostic factor in clear cell renal cell carcinoma MS Broggi, D Patil, Y Baum, PT Nieh, M Alemozaffar, JG Pattaras, K Ogan, ... Urology 96, 99-105, 2016 | 42 | 2016 |
| MRI quantitation of abdominal skeletal muscle correlates with CT-based analysis: implications for sarcopenia measurement AI Khan, DA Reiter, A Sekhar, P Sharma, NM Safdar, DH Patil, SP Psutka, ... Applied Physiology, Nutrition, and Metabolism 44 (8), 814-819, 2019 | 40 | 2019 |
| A four‐group urine risk classifier for predicting outcomes in patients with prostate cancer SP Connell, M Yazbek‐Hanna, F McCarthy, R Hurst, M Webb, H Curley, ... BJU international 124 (4), 609-620, 2019 | 39 | 2019 |
| Circulating microRNAs in plasma among men with low‐grade and high‐grade prostate cancer at prostate biopsy AC McDonald, M Vira, V Walter, J Shen, JD Raman, MG Sanda, D Patil, ... The Prostate 79 (9), 961-968, 2019 | 35 | 2019 |
| Prospective evaluation of fluciclovine (18F) PET-CT and MRI in detection of recurrent prostate cancer in non-prostatectomy patients O Akin-Akintayo, F Tade, P Mittal, C Moreno, PT Nieh, P Rossi, D Patil, ... European Journal of Radiology 102, 1-8, 2018 | 35 | 2018 |
| Evaluation of programmed cell death protein 1 (PD-1) expression as a prognostic biomarker in patients with clear cell renal cell carcinoma KS Kim, RR Sekar, D Patil, MA Dimarco, HT Kissick, MA Bilen, ... OncoImmunology 7 (4), e1413519, 2018 | 35 | 2018 |
| Sarcopenia and modified Glasgow Prognostic Score predict postsurgical outcomes in localized renal cell carcinoma MI Higgins, DJ Martini, DH Patil, R Nabavizadeh, S Steele, M Williams, ... Cancer 127 (12), 1974-1983, 2021 | 34 | 2021 |
| Detection of prostate cancer‐specific transcripts in extracellular vesicles isolated from post‐DRE urine KL Pellegrini, D Patil, KJS Douglas, G Lee, K Wehrmeyer, M Torlak, ... The Prostate 77 (9), 990-999, 2017 | 34 | 2017 |
| Safety and efficacy of ureteral stent placement at the bedside using local anesthesia P Nourparvar, A Leung, AB Shrewsberry, AD Weiss, D Patil, H Atallah, ... The Journal of urology 195 (6), 1886-1890, 2016 | 33 | 2016 |
| Elevated preoperative neutrophil-to-lymphocyte ratio may be associated with decreased overall survival in patients with metastatic clear cell renal cell carcinoma undergoing … YS Baum, D Patil, JH Huang, S Spetka, M Torlak, PT Nieh, M Alemozaffar, ... Asian Journal of Urology 3 (1), 20-25, 2016 | 31 | 2016 |
Viraj MasterProfessor and Fray F. Marshall Chair of Urological Research, Emory University在 emory.edu 的电子邮件经过验证
